AMMONIA N 13

N/A

Manufactured by 3D Imaging Drug Design and Development LLC

259 FDA adverse event reports analyzed

Last updated: 2026-04-15

About AMMONIA N 13

AMMONIA N 13 is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by 3D Imaging Drug Design and Development LLC. The most commonly reported adverse reactions for AMMONIA N 13 include DRUG ABUSE, COUGH, DEPRESSION, CHEST PAIN, DRUG INEFFECTIVE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for AMMONIA N 13.

Top Adverse Reactions

DRUG ABUSE7 reports
COUGH6 reports
DEPRESSION6 reports
CHEST PAIN5 reports
DRUG INEFFECTIVE5 reports
DYSPNOEA5 reports
NAUSEA5 reports
SUICIDE ATTEMPT5 reports
VOMITING5 reports
ACCIDENTAL EXPOSURE TO PRODUCT4 reports
DRUG HYPERSENSITIVITY4 reports
EYE IRRITATION4 reports
EYE PRURITUS4 reports
GASTRITIS4 reports
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES4 reports
OESOPHAGITIS4 reports
PRODUCTIVE COUGH4 reports
THROAT IRRITATION4 reports
TOXICITY TO VARIOUS AGENTS4 reports
WEIGHT INCREASED4 reports
ASTHENIA3 reports
ASTHMA3 reports
BRONCHOSPASM3 reports
CHEST DISCOMFORT3 reports
CHRONIC SINUSITIS3 reports
COMPLETED SUICIDE3 reports
CUSHINGOID3 reports
DRUG INTERACTION3 reports
DYSPNOEA AT REST3 reports
DYSPNOEA EXERTIONAL3 reports
FATIGUE3 reports
FEELING ABNORMAL3 reports
HEADACHE3 reports
LOWER RESPIRATORY TRACT INFECTION3 reports
MALAISE3 reports
MUSCLE SPASMS3 reports
NASAL CONGESTION3 reports
NASAL MUCOSAL DISORDER3 reports
NASAL SEPTUM DEVIATION3 reports
OBSTRUCTIVE AIRWAYS DISORDER3 reports
OESOPHAGEAL INJURY3 reports
PERCUSSION TEST ABNORMAL3 reports
POISONING DELIBERATE3 reports
PRESYNCOPE3 reports
PYREXIA3 reports
SLEEP DISORDER3 reports
SPUTUM DISCOLOURED3 reports
SWOLLEN TONGUE3 reports
TRACHEAL STENOSIS3 reports
UPPER AIRWAY COUGH SYNDROME3 reports
WHEEZING3 reports
ABDOMINAL DISCOMFORT2 reports
ABDOMINAL PAIN2 reports
ANXIETY2 reports
APHTHOUS ULCER2 reports
ARTHRALGIA2 reports
DEATH2 reports
DECREASED APPETITE2 reports
DIARRHOEA2 reports
DIZZINESS2 reports
FOOD ALLERGY2 reports
INFECTION2 reports
INSOMNIA2 reports
LIP SWELLING2 reports
LYMPHADENOPATHY2 reports
MULTIPLE DRUG OVERDOSE2 reports
MYALGIA2 reports
PAIN2 reports
POISONING2 reports
PRURITUS2 reports
RASH2 reports
STOMATITIS2 reports
SWELLING FACE2 reports
TREMOR2 reports
WEIGHT DECREASED2 reports
ABNORMAL DREAMS1 reports
ACUTE MYOCARDIAL INFARCTION1 reports
ADVERSE DRUG REACTION1 reports
AGGRESSION1 reports
AGITATION1 reports
ALLERGY TO ANIMAL1 reports
ALLERGY TO PLANTS1 reports
ALOPECIA1 reports
ALTERED VISUAL DEPTH PERCEPTION1 reports
AMMONIA ABNORMAL1 reports
AMMONIA INCREASED1 reports
ANGER1 reports
APNOEA1 reports
APPARENT DEATH1 reports
ARTHRITIS1 reports
BACK PAIN1 reports
BILIARY COLIC1 reports
BILIARY OBSTRUCTION1 reports
BLADDER DISORDER1 reports
BLISTER1 reports
BLOOD BICARBONATE INCREASED1 reports
BLOOD CHOLESTEROL ABNORMAL1 reports
BLOOD CHOLESTEROL INCREASED1 reports
BLOOD POTASSIUM INCREASED1 reports
BRADYPHRENIA1 reports

Report Outcomes

Out of 56 classified reports for AMMONIA N 13:

Serious 76.8%Non-Serious 23.2%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female31 (64.6%)
Male17 (35.4%)

Reports by Age

Age 446 reports
Age 482 reports
Age 532 reports
Age 592 reports
Age 772 reports
Age 181 reports
Age 271 reports
Age 281 reports
Age 331 reports
Age 351 reports
Age 381 reports
Age 421 reports
Age 431 reports
Age 471 reports
Age 491 reports
Age 511 reports
Age 561 reports
Age 581 reports
Age 631 reports
Age 641 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with AMMONIA N 13?

This profile reflects 259 FDA FAERS reports that mention AMMONIA N 13. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for AMMONIA N 13?

Frequently reported terms in FAERS include DRUG ABUSE, COUGH, DEPRESSION, CHEST PAIN, DRUG INEFFECTIVE, DYSPNOEA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures AMMONIA N 13?

Labeling and FAERS entries often list 3D Imaging Drug Design and Development LLC in connection with AMMONIA N 13. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.